-
AQST Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Aquestive Therapeutics (AQST)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 77.89 mm | 77.89 mm | 77.89 mm | 77.89 mm | 77.89 mm | 77.89 mm |
Cash burn (monthly) | 3.99 mm | (no burn) | 3.84 mm | 2.92 mm | 3.96 mm | 2.85 mm |
Cash used (since last report) | 16.06 mm | n/a | 15.43 mm | 11.76 mm | 15.93 mm | 11.47 mm |
Cash remaining | 61.84 mm | n/a | 62.46 mm | 66.13 mm | 61.97 mm | 66.43 mm |
Runway (months of cash) | 15.5 | n/a | 16.3 | 22.6 | 15.6 | 23.3 |
13F holders | Current |
---|---|
Total holders | 118 |
Opened positions | 40 |
Closed positions | 19 |
Increased positions | 39 |
Reduced positions | 22 |
13F shares | Current |
---|---|
Total value | 224.19 bn |
Total shares | 58.29 mm |
Total puts | 207.30 k |
Total calls | 516.50 k |
Total put/call ratio | 0.4 |
Largest owners | Shares | Value |
---|---|---|
Bratton Capital Management | 9.81 mm | $48.86 bn |
BlackRock | 5.82 mm | $29.00 bn |
VR Adviser | 5.56 mm | $27.67 bn |
Venrock Healthcare Capital Partners III | 5.56 mm | $24.33 mm |
Vanguard | 4.26 mm | $21.23 bn |
Douglas K Bratton | 3.47 mm | $13.49 mm |
BEN Franklin Resources | 2.77 mm | $13.39 bn |
Armistice Capital | 2.75 mm | $15.51 mm |
MPM Oncology Impact Management | 1.80 mm | $8.95 bn |
Geode Capital Management | 1.67 mm | $8.31 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Dec 24 | Douglas K Bratton | Common Stock | Gift | Dispose G | Yes | No | 0 | 40,000 | 0.00 | 199,841 |
26 Nov 24 | Cassie Jung | Common Stock | Sell | Dispose S | Yes | No | 4.865 | 44 | 214.06 | 0 |
9 Aug 24 | Carl N Kraus | Common Stock | Payment of exercise | Dispose F | No | No | 3.43 | 10,819 | 37.11 k | 251,681 |
20 Jun 24 | Brown Gregory B | Stock Option (Right to Purchase) Common Stock | Grant | Acquire A | No | No | 2.5 | 38,000 | 95.00 k | 38,000 |
20 Jun 24 | Cochran John | Stock Option (Right to Purchase) Common Stock | Grant | Acquire A | No | No | 2.5 | 38,000 | 95.00 k | 38,000 |